Clinical Practice Guidelines for Blood Transfusions
|
|
- Arabella Small
- 8 years ago
- Views:
Transcription
1 Clinical Practice Guidelines for Blood Transfusions Purpose: To provide practice guidelines regarding the transfusion of blood and blood components and to advance the safety and quality of care for the patients receiving blood transfusions. Hospitals and other organizations that transfuse blood or blood components are required under the Joint Commission (JC), the AABB (American Association of Blood Banks), and the College of American Pathologists (CAP) to evaluate and improve the use of these products. Criteria are established here to guide physician practice, against which performance will be measured. The review process and all transfusion guidelines are under the direction of the Hospital Service Organization s (HSO) Transfusion Committee, which consists of a cross-functional group of physicians, management, and staff. General Principles: 1. In many scenarios, restrictive strategies are at least as beneficial to patients, if not superior to more liberal approaches. 2. When applying these guidelines, practitioners must use their training, experience, judgment, and the patient s specific clinical information to make optimal decisions on the patient s behalf. In this context, transfusion orders must document the clinical necessity and justification for the transfusion. 3. Informed consent is required and will include discussion regarding the risks, benefits, and alternatives to allogeneic blood transfusions. Transfusion in certain situations can be inappropriate and can pose unnecessary risks, while offering little or no benefit to patients. Risks include but are not limited to: host immune response to transfusion, transmission of infectious agents, volume overload, and transfusion-related acute lung injury (TRALI). 4. One packed cell unit should be transfused at a time with re-evaluation of the patient s condition and hemoglobin level before further transfusion, unless dictated otherwise by patient s clinical condition. 5. Adverse events related to transfusion will be identified, evaluated, and reported. 6. Blood and blood product transfusions will be documented and monitored; prospective or retrospective reviews will be performed when warranted. A. Guidance for RBC Transfusions in the Adult Inpatient Setting The following guidelines should be considered in any decision to transfuse an adult patient with red blood cells. Guidelines are based upon expert opinion and synthesis of current literature, and are grouped by specific clinical situations. These guidelines should not be construed as requirements to transfuse, only as situations in which transfusion may be beneficial, depending on individual patient needs. Individual patient needs within each clinical situation should be carefully considered when using these guidelines. In general, one unit PRBCs should be transfused at a time, with re-evaluation of the patient s 1
2 condition and hemoglobin level, unless otherwise dictated by the patient s clinical condition (e.g. severe hemorrhagic shock or severe symptoms of inadequate blood oxygen carrying capacity). Providers MUST document reasons for transfusion very clearly in the patient s medical record. This is especially important when a transfusion is administered in exception to the recommended guidelines. When feasible, clinicians are encouraged to consult with their transfusion service when a situation falls outside of standard guidelines. Clinical Indications for Adult Transfusion of Red Blood Cells: Active Bleeding (AB) 1. Hemorrhagic shock with life threatening bleeding, where explicit transfusion protocols are activated, such as Massive Transfusion Protocol 2. Active, non-life threatening bleeding and Hgb <8 g/dl 3. Life threatening bleeding - no Hgb threshold. This criterion will be applied most often in the intra-operative setting Bleeding Risk (BR) 1. Preoperative assessment of surgical bleeding risk a. Hgb <9 g/dl if intraoperative bleeding is b. Hgb <8 g/dl if intraoperative bleeding is not expected to be lifethreatening Anemia (AN) 1. Asymptomatic a. Hgb < 7 g/dl for healthy, asymptomatic, hemodynamically stable inpatients b. Cardiovascular Disease: Hgb < 8 g/dl for asymptomatic inpatients with evidence of preexisting cardiovascular disease or complications 2. Symptomatic a. No Hgb threshold in the setting of acute blood loss or symptomatic, otherwise unexplained anemia, manifested by one or more of below: i. tachycardia or hypotension (e.g., diastolic pressures <60 mm Hg, systolic pressures reduced by 30 mm Hg, especially if unresponsive to fluids) ii. oliguria or anuria iii. other evidence of inadequate oxygen delivery, increased oxygen extraction, reduced central venous or tissue oxygen saturations, elevated lactate, or elevated laboratory indicators of organ failure iv. Otherwise-clinically manifested cardiovascular failure related to anemia or chest pain that is cardiac in nature" 2
3 Special Conditions (SC) - Exempt from Thresholds The presence of certain clinical conditions warrants maintaining a hemoglobin level higher than normally acceptable for an otherwise healthy, asymptomatic anemic patient; therefore patients in the following scenarios may fall outside of the stated guidelines. 1. Hematology/Oncology patients, including any of the following populations: a. Hematology/Bone Marrow Failure or Bone Marrow Transplant (BMT) patients b. Thalassemia or other congenital anemia patients c. Sickle cell syndrome patients d. Patients on protocols for various blood exchange procedures e. Oncology patients 2. Patients on chronic transfusion protocols Research (RE) 1. Patients on clinical research protocols Other (OT) 1. Extracorporeal device priming B. Guidance for RBC Transfusions in the Pediatric Inpatient Setting The following guidelines should be considered while making a decision to transfuse a pediatric patient with red blood cells. These guidelines do not represent requirements to transfuse, but rather characterize suggested thresholds in which transfusion may be beneficial, grouped by specific clinical situations and based upon expert opinion and synthesis of current literature. Individual patient needs within each clinical situation should be carefully considered when using these guidelines. In general, for Pediatric patients, 10 ml/kg or one unit prbcs should be transfused at a time, with reevaluation of the patient s condition and hemoglobin level, unless otherwise dictated by the patient s clinical condition (e.g. severe hemorrhagic shock or severe symptoms of inadequate blood oxygen carrying capacity). Providers MUST document reasons for transfusion very clearly in the patient s medical record. This is especially important when a transfusion is administered in exception to the recommended guidelines. When feasible, clinicians are encouraged to consult with their transfusion service when a situation falls outside of standard guidelines. Clinical Indications for Pediatric Transfusion of Red Blood Cells: Active Bleeding (AB) 1. Hemorrhagic shock with life-threatening bleeding, where explicit transfusion protocols are activated (e.g. Massive Transfusion Protocol at SLCH) 2. Active, non-life threatening bleeding and Hgb <8 g/dl 3
4 Bleeding Risk (BR) 1. Preoperative assessment of surgical bleeding risk a. Hgb <9 g/dl if intraoperative bleeding is b. Hgb <8 g/dl if intraoperative bleeding is not Anemia (AN) 1. Asymptomatic: Hgb <7 g/dl for hemodynamically stable inpatients (including critically ill) who lack symptoms of anemia 2. Symptomatic: Inpatients with symptomatic anemia evidenced by tachycardia, hypotension, and/or specific symptoms/signs of inadequate oxygen delivery Special Conditions (SC) - Exempt from Thresholds The presence of certain clinical conditions warrants maintaining a hemoglobin level higher than normally acceptable for an otherwise healthy, asymptomatic anemic patient; therefore patients in the following scenarios may fall outside of the stated guidelines. 1. Hematology/Oncology patients, including congenital and acquired anemia, cancer, radiation therapy, and bone marrow transplantation populations. 2. RBC exchange transfusion (either manual or apheresis) 3. Premature Neonates (e.g. gestational age < 34 weeks) a. Hgb <10 g/dl for acutely ill neonates b. Hgb <8 g/dl for apnea c. No Threshold for whole blood exchange transfusion 4. In-patients with cyanotic heart disease- Hgb threshold may vary from g/dl, depending upon circumstances Research (RE) 1. Patients on clinical research protocols Other (OT) 1. Extracorporeal device priming 4
5 Guidance for RBC Transfusions in the Adult Inpatient setting AB-1 Hemorrhagic shock with life threatening bleeding, where explicit transfusion protocols are activated, such as Massive Transfusion Protocol Active Bleeding (AB) Guidance for RBC Transfusions in the Pediatric Inpatient setting AB-1 Hemorrhagic shock with life-threatening bleeding, where explicit transfusion protocols are activated (e.g. Massive Transfusion Protocol at SLCH) AB-2 Active, non-life threatening bleeding and Hgb <8 g/dl AB-2 Active, non-life threatening bleeding and Hgb <8 g/dl AB-3 Life threatening bleeding - no Hgb threshold. This criterion will be applied most often in the intraoperative setting Preoperative Assessment of Surgical Bleeding Risk (BR) BR-1a Hgb <9 g/dl if intraoperative bleeding is BR-1a Hgb <9 g/dl if intraoperative bleeding is BR-1b Hgb <8 g/dl if intraoperative bleeding is not BR-1b Hgb <8 g/dl if intraoperative bleeding is not Anemia (AN) AN-1a Asymptomatic: Hgb < 7 g/dl for healthy, asymptomatic, hemodynamically stable inpatients AN-1b Asymptomatic: Cardiovascular Disease - Hgb < 8 g/dl with evidence of preexisting cardiovascular disease or complications AN-2a Symptomatic: No Hgb threshold in the setting of acute blood loss or symptomatic, otherwise unexplained anemia, manifested by one or more of below: AN-2a i tachycardia or hypotension (e.g., diastolic pressures <60 mm Hg, systolic pressures reduced by 30 mm Hg, especially if unresponsive to fluids) AN-2a ii AN-2a iii AN-2a iv oliguria or anuria other evidence of inadequate oxygen delivery, increased oxygen extraction, reduced central venous or tissue oxygen saturations, elevated lactate, or elevated laboratory indicators of organ failure "Otherwise-clinically manifested cardiovascular failure related to anemia or chest pain that is cardiac in nature" AN-1 Asymptomatic: Hgb < 7 g/dl for hemodynamically stable inpatients (including critically ill) who lack symptoms of anemia AN-2 Symptomatic: In-patients with symptomatic anemia- evidenced by tachycardia, hypotension, and/or specific symptoms/signs of inadequate oxygen delivery 5
6 The presence of certain clinical conditions warrants maintaining a hemoglobin level higher than normally acceptable for an otherwise healthy, asymptomatic anemic patient; therefore patients in the following scenarios may fall outside of the stated guidelines. SC-1 Hematology/Oncology patients, including any of the following populations: SC-1a Hematology/Bone Marrow Failure or Bone Marrow Transplant (BMT) patients SC-1b Thalassemia or other congenital anemia patients SC-1c Sickle cell syndrome patients SC-1d Patients on protocols for various blood exchange procedures SC-1e Oncology patients SC-2 Patients on chronic transfusion protocols RE-1 Patients on clinical research protocols OT-1 Extracorporeal device priming Special Conditions (SC)- Exempt from Thresholds The presence of certain clinical conditions warrants maintaining a hemoglobin level higher than normally acceptable for an otherwise healthy, asymptomatic anemic patient; therefore patients in the following scenarios may fall outside of the stated guidelines. SC-1 Hematology/Oncology patients, including congenital and acquired anemia, cancer, radiation therapy, and bone marrow transplantation populations SC-2 RBC exchange transfusion (either manual or apheresis) SC-3a Premature Neonates (e.g. gestational age < 34 weeks)- Hgb < 10 g/dl if acutely ill SC-3b Premature Neonates (e.g. gestational age < 34 weeks)- Hgb < 8 g/dl for apnea SC-3c Premature Neonates (e.g. gestational age < 34 weeks)- No threshold for whole blood exchange transfusion SC-4 In-patients with cyanotic heart disease- Hgb threshold may vary from g/dl, depending upon circumstances Research (RE) RE-1 Patients on clinical research protocols Other (OT) OT-1 Extracorporeal device priming ***Disclaimer*** This document will be updated periodically as new evidence becomes available and with the expertise of the Lab & Transfusion CEC Members. Additional guidance for transfusion practices with other blood products and components will be addressed with upcoming PBM phases. Center for Clinical Excellence Outcomes Team will be responsible for versioning and repository management via a BJC Patient Blood Management (PBM) SharePoint site. 6
7 References: 1. Macpherson J, Mahoney CB, Katz L, Haarmann J, Bianco C. Contribution of blood to hospital revenue in the United States. Transfusion. Aug 2007;47(2 Suppl):114S-116S; discussion 117S- 119S. 2. Leach Bennett J, Blajchman MA, Delage G, Fearon M, Devine D. Proceedings of a consensus conference: Risk-Based Decision Making for Blood Safety. Transfusion medicine reviews. Oct 2011;25(4): Frank SM, Savage WJ, Rothschild JA, et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology. Jul 2012;117(1): Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. The New England journal of medicine. Feb ;340(6): Blajchman MA. Landmark studies that have changed the practice of transfusion medicine. Transfusion. Sep 2005;45(9): Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. The New England journal of medicine. Dec ;365(26): Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. The New England journal of medicine. Jan ;368(1): Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. The New England journal of medicine. Oct ;371(15): Hebert PC, Carson JL. Transfusion threshold of 7 g per deciliter--the new normal. The New England journal of medicine. Oct ;371(15): Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Critical care medicine. Sep 2008;36(9): Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. Jama. Oct ;304(14): Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Annals of internal medicine. Jul ;157(1): Boucher BA, Hannon TJ. Blood management: a primer for clinicians. Pharmacotherapy. Oct 2007;27(10): Reason J. Human Error. Cambridge, UK: Cambridge University Press; Additional Resources: AABB Technical Manual, Current Edition American Society of Anesthesiologists CAP Guidelines Transfusion Medicine, TRM Standards for Blood Banks and Transfusion Services, Current Edition Society for the Advancement of Blood Management Society of Critical Care Medicine Society of Thoracic Surgeons 7
Introduction to Blood Management
Introduction to Blood Management What is Blood Management? Preventing a blood transfusion to the patient who doesn t need one Right blood product, at the right time, in the right dose, to the right patient
More informationSARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES
SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES TABLE OF CONTENTS SUBJECT PAGE ADULT CRITERIA Red Blood Cells/Autologous 2 Washed Red Blood Cells 2 Cryoprecipitate
More informationPreoperative Laboratory and Diagnostic Studies
Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no
More informationBUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN
BUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN R. Phillip Dellinger MD, MSc, MCCM Professor of Medicine Cooper Medical School of Rowan University Professor of Medicine University Medicine and Dentistry of
More informationSpecific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology
Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also
More informationHydroxyurea Treatment for Sickle Cell Disease
Hydroxyurea Treatment for Sickle Cell Disease Before hydroxyurea After hydroxyurea Hydroxyurea Treatment for Sickle Cell Disease 1 This document is not intended to take the place of the care and attention
More informationTherapeutic Treatment Options: Chronic Blood Transfusions Bone Marrow Transplantation. Marianne E. McPherson Yee, MD, MSc
Therapeutic Treatment Options: Chronic Blood Transfusions Bone Marrow Transplantation Marianne E. McPherson Yee, MD, MSc Sickle Cell Treatment Options Supportive Care Newborn Screen PCN Immunizations Education
More informationBUILDING AND SUSTAINING A BLOOD MANAGEMENT PROGRAM
SHERIDAN LEADERSHIP BRIEF BUILDING AND SUSTAINING A BLOOD MANAGEMENT PROGRAM How Creating and Implementing Standards for Transfusions Resulted in Better Clinical Outcomes and Cost Savings for Hospitals
More informationRed Blood Cell Transfusions for Sickle Cell Disease
Red Blood Cell Transfusions for Sickle Cell Disease Red Blood Cell Transfusions for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital, Departments of Hematology, Patient Education,
More informationSubject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013
Stony Brook Medicine Severe Sepsis/Septic Shock Recognition and Treatment Protocols Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August
More informationHow To Choose A Pediatric Oncologist
Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the
More informationRole of the Medical Director
Role of the Medical Director Beth Shaz, MD Assistant Professor, Emory University School of Medicine Director, Transfusion Services, Grady Memorial Hospital Atlanta, GA 1.1.1 Medical Director Responsibilities
More informationBone Marrow/Stem Cell Transplant
Blue Distinction Centers for Transplants Program Selection Criteria for 2010 Mid-Point Designations To qualify as a Blue Distinction Center for Transplants (), each facility must satisfy s quality based
More informationECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
More informationPlumbing 101:! TXA and EMS! Jay H. Reich, MD FACEP! EMS Medical Director! City of Kansas City, Missouri/Kansas City Fire Department!
Plumbing 101:! TXA and EMS! Jay H. Reich, MD FACEP! EMS Medical Director! City of Kansas City, Missouri/Kansas City Fire Department! EMS Section Chief! Department of Emergency Medicine! University of Missouri-Kansas
More informationThe Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy
The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting
More informationNavigating the Regulatory Issues of Blood Management
Navigating the Regulatory Issues of Blood Management Bob Dyga RN, CCP, LP, CPBMT Vice President, Perfusion Operations UPMC/Procirca History of Transfusion Medicine Blundell s Blood Gravitator h2p://bloodjournal.hematologylibrary.org/content/112/7/2617/f5.large.jpg
More informationBlood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide
Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood
More informationBusiness Concept: Anemia Center/Clinic/Service Proposal submitted by Department of Blood Management
Business Concept: Anemia Center/Clinic/Service Proposal submitted by Department of Blood Management Concept Name Anemia Center/Clinic/Service, Pre-op Treatment Center, Blood Management Outpatient Service,
More informationBlood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.
Blood Transfusion Introduction Blood transfusions can save lives. Every second, someone in the world needs a blood transfusion. Blood transfusions can replace the blood lost from a serious injury or surgery.
More informationSuggestions for Optimizing Use of Plasma in the Era of TRALI Risk Reduction
Suggestions for Optimizing Use of Plasma in the Era of TRALI Risk Reduction March 27, 2014 Steve Kleinman, MD TRALI: A brief history Identified as a non-infectious serious hazard of transfusion in the
More informationPrioritizing Comparative Effectiveness Research Questions: PCORI Stakeholder Workshops. March 7, 2016
Prioritizing Comparative Effectiveness Research Questions for Management of Sickle Cell Disease: Questions submitted for consideration by workshop participants Prioritizing Comparative Effectiveness Research
More informationTranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies
Overview Where We Use It And Why Andreas Antoniou, M.D., M.Sc. Department of Anesthesia and Perioperative Medicine University of Western Ontario November 14 th, 2009 Hemostasis Fibrinolysis Aprotinin and
More informationBlood Transfusion. Red Blood Cells White Blood Cells Platelets
Blood Transfusion Introduction Blood transfusions are very common. Each year, almost 5 million Americans need a blood transfusion. Blood transfusions are given to replace blood lost during surgery or serious
More informationLABORATORY PROCEDURE MANUAL
Exercise 2 Donor Physical Exam Textbook: Skills: 20 points Objectives 1. For each of the following state the acceptable values for blood donation using appropriate units: a. Pulse b. Temperature (Celsius
More informationSample Consent. Transfusion of Prematures (TOP)
Final: October 8. 2012 Revised: February 8. 2013 Appendix A: Sample Consent ~ Penn Medicine,~. Informed Consent Form and HIPAA Authorization Protocol Title: Short Title: Principal Investigator: Emergency
More informationTransfusion Medicine
Transfusion Medicine Chapter 5 Transfusion Medicine Routine Transfusion Therapy Blood products should not be transfused on a unit basis in children Base the volume of transfusion products on weight to
More informationTRANSFUSION MEDICINE
TRANSFUSION MEDICINE Transfusion medicine is a one-month per year rotation for a total of three months. During each rotation the resident is exposed to the basic concepts of transfusion medicine. Specific
More informationGetting Ready for Patient Blood Management Certification. Steve Frank, MD Eduardo Nunes, MPP, CAE Stacy Olea, MT(ASCP), FACHE May 12, 2016
Getting Ready for Patient Blood Management Certification Steve Frank, MD Eduardo Nunes, MPP, CAE Stacy Olea, MT(ASCP), FACHE May 12, 2016 Collaborative Product Offering First product to be co-developed
More informationGRANIX (tbo-filgrastim)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil
More informationCCS - Does CCS provide Counseling or Support Services? CCS - Are there any costs to me? CCS - What papers should I bring?
CCS - Does CCS provide Counseling or Support Services? CCS - Are there any costs to me? CCS - What papers should I bring? CCS - What are the steps to CCS services? CCS - How is my privacy protected? CCS
More informationDecreasing Sepsis Mortality at the University of Colorado Hospital
Decreasing Sepsis Mortality at the University of Colorado Hospital Maureen Dzialo, RN, BSN - Nurse Manager, Cardiac Intensive Care Unit Olivia Kerveillant, RN Clinical Nurse III, Medical Intensive Care
More informationcord blood saves lives...
cord blood saves lives... ...by providing a rich source of blood stem cells that can be used to treat over 80 different diseases including leukemia, lymphoma, thalassemia, Tay-Sachs and sickle cell anemia.
More informationAutomatic External Defibrillators
Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationInpatient Code Sepsis March Update. Sarah Prebil
Inpatient Code Sepsis March Update Sarah Prebil 3 hour bundle Time is life Kumar et al. Crit Care Med 2006; 34:1589-1596 But Sarah, why are you harassing us about sepsis? Pilot Results 10 Code Sepsis pabents
More informationCENTER FOR DRUG EVALUATION AND RESEARCH
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 205029Orig1s000 SUMMARY REVIEW Cross Discipline Team Leader Review 4. Nonclinical Pharmacology/Toxicology In their review of the original application,
More informationElectronic Health Record Strategies for Pay for Performance. James O Connor MD Director of Clinical Informatics
Electronic Health Record Strategies for Pay for Performance This Title is Copy where the title would go. James O Connor MD Director of Clinical Informatics Early Days of EMR... Access to Records E&M Coding
More informationIt s not something you want to think about, but it s something you want to prepare for.
It s not something you want to think about, but it s something you want to prepare for. StemCyte cord blood banking offers your family a new lifesaving treatment alternative Why Bank Take the once-in-alifetime
More informationDEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT
www.narayanahealth.org DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service providers
More informationCancer services children s CSCF v3.2
Cancer services children s CSCF v3.2 Module overview Please note: This module should be read in conjunction with the Fundamentals of the Framework (including glossary and acronym list), Children s Services
More informationSICKLE CELL DISEASE IN GEORGIA
SICKLE CELL DISEASE IN GEORGIA Peter A Lane, MD Professor of Pediatrics Emory University School of Medicine Director, Sickle Cell Disease Program Children s Healthcare of Atlanta SICKLE CELL DISEASE IN
More informationOmega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9
Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer
More informationThe Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome
Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali
More informationCORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM
APPENDIX A SAMPLE CONSENT FORM CORD BLOOD TRANSPLANTATION (COBLT) STUDY SAMPLE CONSENT FORM FOR THE EXPANDED ACCESS PROTOCOL You (your child) are being asked to take part in a clinical research study.
More informationDenominator Statement: Cardiac surgery patients with no evidence of prior infection.
Last Updated: Version 4.3b NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form CMS/The Joint Commission: Suspended (Effective immediately beginning with July 1, 2014 discharges)
More informationSchool-age child 5-1 THE BLOOD
C A S E S T U D Y 5 : School-age child Adapted from Thomson Delmar Learning s Case Study Series: Pediatrics, by Bonita E. Broyles, RN, BSN, MA, PhD. Copyright 2006 Thomson Delmar Learning, Clifton Park,
More informationFDA Considerations Regarding Frequent Plasma Collection Procedures
FDA Considerations Regarding Frequent Plasma Collection Procedures Alan E. Williams, Ph.D. Office of Blood Research and Review Center for Biologics Evaluation and Research US Food and Drug Administration
More informationYvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI
Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI Overview of Hematology, http://www.nu.edu.sa/userfiles/mhmorsy/h
More informationJamie Peregrine, MD, PGY-4 KU-Wichita, OB/GYN Wesley Medical Center
Jamie Peregrine, MD, PGY-4 KU-Wichita, OB/GYN Wesley Medical Center Uses for umbilical cord stem cells Describe the indications and uses for umbilical cord stem cells. Counsel patients on the advantages
More informationBLOOD COLLECTION. How much blood is donated each year and how much is used?
BLOOD COLLECTION How much blood is donated each year and how much is used? Each unit of blood consists of a volume of 450-500 milliliters or about one pint. Because of the constant demand for blood, about
More informationDetermining Donor Eligibility Blood Donor vs. Stem Cell Donor. Wanda Koetz, RN, HPC Clinical Nurse Lead, Memorial Blood Centers ASFA - May 7, 2015
Determining Donor Eligibility Blood Donor vs. Stem Cell Donor Wanda Koetz, RN, HPC Clinical Nurse Lead, Memorial Blood Centers ASFA - May 7, 2015 Objectives The learner will be able to: Define donor eligibility
More informationELSO GUIDELINES FOR TRAINING AND CONTINUING EDUCATION OF ECMO SPECIALISTS
ELSO GUIDELINES FOR TRAINING AND CONTINUING EDUCATION OF ECMO SPECIALISTS PURPOSE The "" is a document developed by the Extracorporeal Life Support Organization (ELSO) as a reference for current and future
More informationLynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor. No disclosures
Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor No disclosures 1 2 3 Discuss data requirements -3 hour bundle -6 hour bundle Challenges and compliance issues Success 4 Based on the Surviving Sepsis
More informationAktuelle Literatur aus der Notfallmedizin
05.02.2014 Aktuelle Literatur aus der Notfallmedizin prä- und innerklinisch Aktuelle Publikationen aus 2012 / 2013 PubMed hits zu emergency medicine 12,599 Abstract OBJECTIVES: Current American Heart
More informationASSEMBLY, No. 2591 STATE OF NEW JERSEY. 212th LEGISLATURE INTRODUCED FEBRUARY 23, 2006
ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Assemblywoman CHARLOTTE VANDERVALK District (Bergen) SYNOPSIS Requires hospitals to provide information to pregnant
More informationDepartment of Anesthesia & Perioperative Medicine 5-Year Strategic Plan FY 2012-2016. Contents
Anesthesia & Perioperative Medicine 167 Ashley Avenue, Suite 301 MSC 912 Charleston, SC 29425-9120 Tel 843 792 2322 Fax 843 792 9314 Department of Anesthesia & Perioperative Medicine 5-Year Strategic Plan
More informationSTEM CELL TRANSPLANTS
UAMS Information on STEM CELL TRANSPLANTS What is a Stem Cell Transplant? A stem cell transplant is an infusion of stem cells following high-dose chemotherapy. The infused cells effectively rescue the
More informationHuman Clinical Study for Free Testosterone & Muscle Mass Boosting
Human Clinical Study for Free Testosterone & Muscle Mass Boosting GE Nutrients, Inc. 920 E. Orangethorpe Avenue, Suite B Anaheim, California 92801, USA Phone: +1-714-870-8723 Fax: +1-732-875-0306 Contact
More informationSeries 1 Case Studies Adverse Events that Represent Unanticipated Problems: Reporting Required
Welcome! This document contains three (3) series of Case Study examples that will demonstrate all four OHSU reporting categories (#1 4) as well as examples of events that are considered not reportable.
More informationA Cure for Sickle Cell Anemia and Thalassemia
IV Simpósio Internacional de Hemoglobinopatias A Cure for Sickle Cell Anemia and Thalassemia Bertram Lubin, MD and Mark Walters, MD 4 September 2007 Topics to be covered Cord blood: Importance and biology
More informationMayo Clinic College of Medicine Pharmacy Services. Rotation Summary
Mayo Clinic College of Medicine Pharmacy Services Rotation Summary Rotation Title: PGY-2 Pediatric Hematology-Oncology Rotation Length: 3-6 weeks Primary Preceptor Name: Amanda Kuper, PharmD, BPCS, Ron
More informationPT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank
Cordblood Stem Cells and The Role of Cordblood Bank in Supporting Stem Cells Research Presentation Overview Company profile Haematopoietic stem cells in cordblood What we can do to help 1 2 PT CordLife
More informationELSO GUIDELINES FOR ECMO CENTERS
ELSO GUIDELINES FOR ECMO CENTERS PURPOSE These guidelines developed by the Extracorporeal Life Support Organization, outline the ideal institutional requirements needed for effective use of extracorporeal
More informationYour Guide to Express Critical Illness Insurance Definitions
Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses
More informationThe American Heart Association released new resuscitation science and treatment guidelines on October 19, 2010.
ACLS Study Guide The American Heart Association released new resuscitation science and treatment guidelines on October 19, 2010. Please read the below information carefully This letter is to confirm your
More informationChildren's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire
Children's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire Date: RPICC Facility: CMS use only Include the following
More informationCODE AUDITING RULES. SAMPLE Medical Policy Rationale
CODE AUDITING RULES As part of Coventry Health Care of Missouri, Inc s commitment to improve business processes, we are implemented a new payment policy program that applies to claims processed on August
More informationUMBILICAL CORD BLOOD COLLECTION
UMBILICAL CORD BLOOD COLLECTION by Frances Verter, PhD Founder & Director, Parent's Guide to Cord Blood Foundation info@parentsguidecordblood.org and Kim Petrella, RN Department of Obstetrics and Gynecology
More informationINFORMED CONSENT FOR SLEEVE GASTRECTOMY
INFORMED CONSENT FOR SLEEVE GASTRECTOMY This informed-consent document has been prepared to help inform you about your Sleeve Gastrectomy including the risks and benefits, as well as alternative treatments.
More informationMedical Direction and Practices Board WHITE PAPER
Medical Direction and Practices Board WHITE PAPER Use of Pressors in Pre-Hospital Medicine: Proper Indication and State of the Science Regarding Proper Choice of Pressor BACKGROUND Shock is caused by a
More informationA Gift for life. HTA Licence No. 22653
A Gift for life HTA Licence No. 22653 2 3 the best possible gift for your new born child. 4 6 8 9 10 12 14 16 19 what is cord blood current treatments services contents properties for treatment process
More informationHelping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.
Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.CA WWW This guide is intended for patients in need of an unrelated volunteer
More informationVenous Thromboembolic Treatment Guidelines
Venous Thromboembolic Treatment Guidelines About the NYU Venous Thromboembolic Center (VTEC) The center s mission is to deliver advanced screening, detection, care, and management services for patients
More informationBone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation
More informationObjectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History
Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize
More informationCommon Surgical Procedures in the Elderly
Common Surgical Procedures in the Elderly From hip and knee replacements to cataract and heart surgery, America s elderly undergo 20% of all surgical procedures. For a group that comprises only 13% of
More informationNarrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
More informationMANAGING ANEMIA. When You Have Kidney Disease or Kidney Failure. www.kidney.org
MANAGING ANEMIA When You Have Kidney Disease or Kidney Failure www.kidney.org About the Information in this Booklet Did you know that the National Kidney Foundation (NKF) offers guidelines and commentaries
More informationHe then needs to work closely with the Quality Management Director or Leader and the Risk Manager to monitor the provision of patient care.
Chapter II Introduction The Director has a major role in the effort to provide high quality medical care with a high degree of clinical safety. He is ultimately responsible for the professional conduct
More informationChapter 16. Learning Objectives. Learning Objectives 9/11/2012. Shock. Explain difference between compensated and uncompensated shock
Chapter 16 Shock Learning Objectives Explain difference between compensated and uncompensated shock Differentiate among 5 causes and types of shock: Hypovolemic Cardiogenic Neurogenic Septic Anaphylactic
More informationRecommendations: Other Supportive Therapy of Severe Sepsis*
Recommendations: Other Supportive Therapy of Severe Sepsis* K. Blood Product Administration 1. Once tissue hypoperfusion has resolved and in the absence of extenuating circumstances, such as myocardial
More informationElenco dei periodici elettronici in Ovid Full text
Academic Medicine Addictive Disorders & Their Treatment Advances in Anatomic Pathology Age & Ageing AIDS AIDS Patient Care & Stds AJN, American Journal of Nursing Alzheimer Disease & Associated Disorders
More informationTransplant Coordinator
Have you signed your organ donor card? Hearts, kidneys, livers, and lungs can all be transplanted. When you die, one of your organs could help a critically ill patient live a longer life. What I do every
More informationA retreat for children with life-threatening illnesses and their families Family Application 2016 Sickle Cell Program
A retreat for children with life-threatening illnesses and their families Family Application 2016 Sickle Cell Program Please complete and return this application to the Camp Sunshine office. Please Note:
More informationDVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular
More informationDonor Adverse Events
Donor Adverse Events Common terminology Frequency Risk factors Hold still, Mrs. Brown, while I draw your blood Mindy Goldman, MD Canadian Blood Services IHN Seminar, Paris March 11, 2016 Outline Donor
More informationINTRODUCTION TO EECP THERAPY
INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and
More informationSpecific Standards of Accreditation for Residency Programs in General Surgery
Specific Standards of Accreditation for Residency Programs in General Surgery 2010 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation of the
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationScope and Standards for Nurse Anesthesia Practice
Scope and Standards for Nurse Anesthesia Practice Copyright 2010 222 South Prospect Ave. Park Ridge, IL 60068 www.aana.com Scope and Standards for Nurse Anesthesia Practice The AANA Scope and Standards
More informationCord Blood Stem Cell Transplantation
LEUKEMIA LYMPHOMA MYELOMA FACTS Cord Blood Stem Cell Transplantation No. 2 in a series providing the latest information on blood cancers Highlights Umbilical cord blood, like bone marrow and peripheral
More informationFrequently Asked Questions
Frequently Asked Questions Who founded the American Red Cross? Clara Barton (1821-1912) dominates the early history of the American Red Cross, which was modeled after the International Red Cross. She did
More informationBone Marrow (Stem Cell) Transplant for Sickle Cell Disease
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient
More informationLOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER - SHREVEPORT MEDICAL RECORDS CONTENT/DOCUMENTATION
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER - SHREVEPORT MEDICAL RECORDS CONTENT/DOCUMENTATION Hospital Policy Manual Purpose: To define the components of the paper and electronic medical record
More information- 301-17. SICKLE CELL SCREENING AND SELECT TOPICS IN PREVENTION OF COMPLICATIONS Mark Schuster, M.D., Ph.D.
- 301-17. SICKLE CELL SCREENING AND SELECT TOPICS IN PREVENTION OF COMPLICATIONS Mark Schuster, M.D., Ph.D. We used the following sources to construct indicators for sickle cell disease screening for newborns
More informationBlood-Forming Stem Cell Transplants
Blood-Forming Stem Cell Transplants What are bone marrow and hematopoietic stem cells? Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic
More informationSecure Messaging Evidence Table
APPENDIX E. Evidence Tables Secure Messaging Evidence Table Health Outcomes Simon, 2011 9 RCT; N=208 patients; 04/09-10/09 Elkjaer, 2010 1 Zhou, 2010 2 Harris, 2009 3 Ralston, 2009 6 Tuil, 2007 4 RCT;
More informationMaster of Physician Assistant Studies Course Descriptions for Year I
FALL TERM COURSES: Master of Physician Assistant Studies Course Descriptions for Year I PHAC 7230 Fundamentals in Pharmacology for Health Care I Credit Hrs: 3 This course will build on foundational knowledge
More informationMultiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
More informationFacing Lung Cancer? Learn why da Vinci Surgery may be your best treatment option for lung cancer.
Facing Lung Cancer? Learn why da Vinci Surgery may be your best treatment option for lung cancer. The Condition: Lung Cancer The lung is the organ that moves oxygen through your body. You have two lungs
More information